EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Omega-3 fatty acids for cardiovascular event lowering

Gurleen Kaur, R Preston Mason, Ph Gabriel Steg, Deepak L Bhatt iD

European Journal of Preventive Cardiology · 2024

DOI: 10.1093/eurjpc/zwae003 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Preventive Cardiology, 2024. Verfasst von Gurleen Kaur und 3 weiteren Autor:innen. Beteiligte Einrichtung: Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Fatty Acids, Omega-3. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Low-density lipoprotein cholesterol (LDL-C) is the main target for therapeutics aimed at reducing the risk of atherosclerotic cardiovascular disease (ASCVD) and downstream cardiovascular (CV) events. However, multiple studies have demonstrated that high-risk patient populations harbour residual risk despite effective LDL-C lowering. While data support the causal relationship between triglycerides and ASCVD risk, triglyceride-lowering therapies such as omega-3 fatty acids have shown mixed results in CV outcomes trials. Notably, icosapent ethyl, a purified formulation of eicosapentaenoic acid (EPA), has garnered compelling evidence in lowering residual CV risk in patients with hypertriglyceridaemia and treated with statins. In this review, we summarize studies that have investigated omega-3-fatty acids for CV event lowering and discuss the clinical implementation of these agents based on trial data and guidelines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesFatty Acids, Omega-3HumansTreatment OutcomeBiomarkersHeart Disease Risk FactorsEicosapentaenoic Acid

Stichwörter der Autor:innen

atherosclerotic cardiovascular diseaseicosapent ethylomega-3 fatty acids

Substanzen

Fatty Acids, Omega-3BiomarkersEicosapentaenoic Acid

Autor:innen und Institutionen

  • Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Elucida Research LLC, Beverly, MA, USA.
  • Paris Cité University, Public Hospitals of Paris (AP-HP), Bichat Hospital, Paris, France.
  • Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

ORCID-Profile: Deepak L Bhatt

Zitieren

APA

Kaur, G., Mason, R. P., Steg, P. G., & Bhatt, D. L. (2024). Omega-3 fatty acids for cardiovascular event lowering. European Journal of Preventive Cardiology. https://doi.org/10.1093/eurjpc/zwae003

Vancouver

Kaur G, Mason RP, Steg PG, Bhatt DL. Omega-3 fatty acids for cardiovascular event lowering. European Journal of Preventive Cardiology. 2024. doi:10.1093/eurjpc/zwae003

BibTeX
@article{Kaur2024,
  author = {Kaur, Gurleen and Mason, R Preston and Steg, Ph Gabriel and Bhatt, Deepak L},
  title = {Omega-3 fatty acids for cardiovascular event lowering},
  journal = {European Journal of Preventive Cardiology},
  year = {2024},
  doi = {10.1093/eurjpc/zwae003}
}
Kostenlos starten →